Lipocine Inc
LPCN2.880USD
+0.070+2.49%
收盘 09/19, 16:00（美东）报价延迟15分钟
15.48M总市值
亏损市盈率 TTM
关于 Lipocine Inc 公司
Lipocine Inc. 是一家生物制药公司，利用其专有技术平台通过有效的口服给药增强治疗效果，开发用于中枢神经系统 (CNS) 疾病的差异化产品。其临床开发候选药物包括：LPCN 1154（口服 brexanolone，用于治疗产后抑郁症）、LPCN 2101（用于治疗癫痫）、LPCN 2203（用于治疗特发性震颤）和 LPCN 1148（一种新型雄激素受体激动剂前药，用于口服给药，旨在治疗与肝硬化相关的症状）。该公司正在探索 LPCN 1107（用于预防早产）、LPCN1154（用于快速缓解产后抑郁症）、LPCN 1148（用于治疗失代偿性肝硬化）和 LPCN 1144（用于治疗非肝硬化 NASH）的合作机会。其候选产品 TLANDO 是一种口服治疗药物，用于成年男性的睾酮替代疗法，治疗与内源性睾酮缺乏或缺失相关的疾病。
公司简介
公司代码LPCN
公司名称Lipocine Inc
上市日期Mar 21, 2014
CEODr. Mahesh V. Patel, Ph.D.
员工数量16
证券类型Ordinary Share
年结日Mar 21
公司地址675 S Arapeen Dr Ste 202
城市SALT LAKE CITY
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编84108-1295
电话18019947383
网址https://www.lipocine.com/
公司代码LPCN
上市日期Mar 21, 2014
CEODr. Mahesh V. Patel, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Mahesh V. Patel, Ph.D.
Dr. Mahesh V. Patel, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.05K
+1.52%
Mr. John W. Higuchi
Mr. John W. Higuchi
Director
Director
40.80K
--
Dr. Nachiappan Chidambaram, Ph.D.
Dr. Nachiappan Chidambaram, Ph.D.
Senior Vice President - Research and Development
Senior Vice President - Research and Development
4.41K
+11.54%
Ms. Krista Fogarty
Ms. Krista Fogarty
Principal Accounting Officer, Corporate Controller
Principal Accounting Officer, Corporate Controller
1.07K
+44.84%
Dr. Richard Dana Ono, Ph.D.
Dr. Richard Dana Ono, Ph.D.
Independent Director
Independent Director
831.00
--
Mr. Jeffrey A. (Jeff) Fink
Mr. Jeffrey A. (Jeff) Fink
Independent Director
Independent Director
386.00
--
Dr. Jill M. Jene, Ph.D.
Dr. Jill M. Jene, Ph.D.
Independent Director
Independent Director
--
--
Mr. Spyros Papapetropoulos, M.D., Ph.D.
Mr. Spyros Papapetropoulos, M.D., Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Mahesh V. Patel, Ph.D.
Dr. Mahesh V. Patel, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.05K
+1.52%
Mr. John W. Higuchi
Mr. John W. Higuchi
Director
Director
40.80K
--
Dr. Nachiappan Chidambaram, Ph.D.
Dr. Nachiappan Chidambaram, Ph.D.
Senior Vice President - Research and Development
Senior Vice President - Research and Development
4.41K
+11.54%
Ms. Krista Fogarty
Ms. Krista Fogarty
Principal Accounting Officer, Corporate Controller
Principal Accounting Officer, Corporate Controller
1.07K
+44.84%
Dr. Richard Dana Ono, Ph.D.
Dr. Richard Dana Ono, Ph.D.
Independent Director
Independent Director
831.00
--
Mr. Jeffrey A. (Jeff) Fink
Mr. Jeffrey A. (Jeff) Fink
Independent Director
Independent Director
386.00
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月17日 周日
更新时间: 8月17日 周日
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
4.15%
Patel (Mahesh V)
2.01%
BlackRock Institutional Trust Company, N.A.
1.65%
Geode Capital Management, L.L.C.
1.13%
Susquehanna International Group, LLP
0.85%
其他
90.21%
持股股东
持股股东
占比
The Vanguard Group, Inc.
4.15%
Patel (Mahesh V)
2.01%
BlackRock Institutional Trust Company, N.A.
1.65%
Geode Capital Management, L.L.C.
1.13%
Susquehanna International Group, LLP
0.85%
其他
90.21%
股东类型
持股股东
占比
Investment Advisor
6.95%
Individual Investor
2.91%
Investment Advisor/Hedge Fund
2.15%
Hedge Fund
0.65%
Research Firm
0.05%
其他
87.28%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
44
680.47K
12.56%
-41.55K
2025Q1
65
678.55K
12.68%
-110.89K
2024Q4
72
645.33K
12.07%
-219.30K
2024Q3
75
703.77K
13.16%
-136.61K
2024Q2
79
690.86K
12.92%
-132.01K
2024Q1
82
639.82K
12.02%
-214.82K
2023Q4
86
649.80K
12.29%
-222.39K
2023Q3
91
667.07K
12.61%
-176.35K
2023Q2
93
641.50K
12.32%
-239.33K
2023Q1
97
745.08K
14.31%
-142.00K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
226.28K
4.23%
+4.82K
+2.18%
Mar 31, 2025
Patel (Mahesh V)
109.05K
2.04%
+1.63K
+1.52%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
89.27K
1.67%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
58.83K
1.1%
+1.37K
+2.38%
Mar 31, 2025
Susquehanna International Group, LLP
38.98K
0.73%
+13.97K
+55.89%
Mar 31, 2025
Higuchi (John W)
40.80K
0.76%
--
--
Mar 31, 2025
Renaissance Technologies LLC
37.51K
0.7%
+1.48K
+4.10%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
24.93K
0.47%
+4.42K
+21.54%
Mar 31, 2025
State Street Global Advisors (US)
18.63K
0.35%
--
--
Mar 31, 2025
Northern Trust Investments, Inc.
13.16K
0.25%
--
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
公告日期
类型
比率
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
May 11, 2023
Merger
17→1
